Bayer has dropped an acute respiratory distress syndrome drug in phase 2 development for “scientific reasons,” the German pharma giant revealed in its latest earnings results. The company “decided not ...
Please provide your email address to receive an email when new articles are posted on . Acetaminophen and placebo use in sepsis both yielded similar numbers of days alive and free of organ support.
LA JOLLA, Calif., June 08, 2022 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the JASDAQ Market of the Tokyo Stock Exchange ...
Please provide your email address to receive an email when new articles are posted on . Researchers observed high lysolipid levels in those with acute respiratory distress syndrome (ARDS), which may ...
Brazil Phase 2 Pivotal clinical trial of COVI-MSC is now authorized to proceed. The study will compare therapy using mesenchymal stem cells to placebo (and standard of care) in 100 COVID-19 patients ...
ELK CITY, Idaho--(BUSINESS WIRE)--Therapeutic Solutions International announced today filing with the Food and Drug Administration (FDA) an amendment to its currently open Phase III clinical trial ...
Direct Biologics Reports Compelling Results From Phase 2 Trial With ExoFlo™ in Hospitalized Patients With Respiratory Failure or Moderate-to-Severe Acute Respiratory Distress Syndrome (ARDS) Due to ...
--Reached agreement with FDA on single Phase 3 clinical trial design to expand treatment population to include all hospitalized adult patients with any type of virus induced ARDS including the ...
A team of international scientists have recently estimated the risk and prevalence of acute respiratory distress syndrome (ARDS) in hospitalized young adults with severe acute respiratory syndrome ...
A team of scientists from Germany has recently conducted a study to investigate the effect of inhaled prostacyclin on the prognosis of acute respiratory distress syndrome (ARDS) induced by coronavirus ...
Acute respiratory distress syndrome (ARDS) represents a severe pulmonary condition in which widespread alveolar inflammation and pulmonary oedema severely compromise gas exchange. The clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results